TickerFacts.

NeuroPace Inc (NPCE): Cost of Revenue

Annual figures by period end, from SEC filings.

$22.77M
Year ended 2025-12-31
+20.5%
3-year compound annual growth
+15.9%
5-year compound annual growth
2020-12-31: $10.87M2021-12-31: $11.75M2022-12-31: $13.03M2023-12-31: $17.30M2024-12-31: $20.82M2025-12-31: $22.77M$22.77M
2020-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$22.77M+9.3%2026-03-03, From 2025-01-01
2024-12-31$20.82M+20.4%2026-03-03, From 2024-01-01
2023-12-31$17.30M+32.8%2025-03-04, From 2023-01-01
2022-12-31$13.03M+10.9%2024-03-05, From 2022-01-01
2021-12-31$11.75M+8.1%2023-03-02, From 2021-01-01
2020-12-31$10.87Mn/a2022-03-10, From 2020-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
NeuroPace Inc (NPCE)2025-12-31$22.77M+9.3%
Beta Bionics, Inc. (BBNX)2025-12-31$44.71M+52.9%
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$46.26M+29.9%
Pulmonx Corp (LUNG)2025-12-31$23.36M+7.2%
Anika Therapeutics, Inc. (ANIK)2025-12-31$49.01M+11.6%
Orasure Technologies Inc (OSUR)2025-12-31$66.82M-37.2%
Delcath Systems, Inc. (DCTH)2025-12-31$11.80M+90.6%
Iradimed Corp (IRMD)2025-12-31$19.49M+15.4%
PRO DEX Inc (PDEX)2026-06-30$53.21M+13.0%

Compare NPCE, BBNX, KMTS, LUNG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗